尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Hsu Frank J.. Officer active across 1 company, notably Apexigen, Inc.. Aggregated, 4 disclosures have been logged. History available since 7 October 2022. The latest transaction was disclosed on 15 June 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Hsu Frank J. is a declarant linked to Apexigen, Inc., where the listed role is Chief Medical Officer. The record shows 4 filings in total, and across the 4 sampled recent filings between 2022-10-11 and 2023-08-25, the euro buy and sell amounts are zero, with tax withholding as the dominant transaction nature.